A study, by Michael Nauck and colleagues from Bad Lauterberg im Harz, Germany, suggests that taspoglutide (R1583), a long-acting (once-weekly) human glucagon-like peptide-1 (GLP-1) analogue, currently under investigation by Roche for the treatment of type 2 diabetes mellitus, may likewise promote modest weight loss (Diabetes Care)
Learn more about Ascorbic Acid Ascorbyl Glucoside (AA-2G) is one of the most stable vitamin C derivatives out there
Q How to find a trustworthy pharmaceutical intermediate supplier for OEM or custom projects
"[E]xendin-4 was discovered in 1992 in the gila monster, after a researcher noticed the gilas venom caused the pancreas of bitten victims to swell." The Potential This strategy has already changed human lives
Speak with a licensed clinician, same-day, all online, whenever you have a question
Szintn kerlend a gygyszer, ha valaki slyos gyomor-blrendszeri panaszokkal (pldul gyomorrlsi zavar gastroparesis) kzd, mivel a GLP-1 agonistk lasstjk a gyomor kirlst, gy ronthatjk a tneteket